Form 4: Forian Inc. Director Acquires Stock Options
SEC Form 4 Filing
Director Mark J Adler MD acquired 15,000 stock options in Forian Inc. on March 27, 2024.
Summary
- On March 27, 2024, Mark J Adler MD, a director of Forian Inc., acquired 15,000 stock options.
- The exercise price of these options is $3.20.
- The options vest in four equal annual installments starting March 27, 2025, contingent upon continued service as a non-employee director.
- The options expire on March 27, 2034.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing regarding stock option grants. It doesn't contain overtly positive or negative information, but the granting of options to a director is generally viewed neutrally to slightly positively as it aligns their interests with shareholders.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard regulatory filing related to insider transactions. It's common for directors to receive stock options as part of their compensation.
Stakeholder Impact
- The granting of stock options to a director could potentially align the director's interests more closely with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction: Mark J Adler MD acquired 15,000 stock options. |
| 03/27/2025 | First vesting date: The stock options vest in four equal annual installments beginning on this date. |
| 03/27/2034 | Expiration date: The stock options expire on this date. |
| 03/28/2024 | Date of filing: The Form 4 was signed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.